logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Simple Partial Seizures

    FiltersReset Filters
    12 results

    • afinitor

      (everolimus)
      Novartis Pharmaceuticals Corporation
      Usage: AFINITOR is indicated for: advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women; progressive neuroendocrine tumors (PNET and non-functional GI/lung type); advanced renal cell carcinoma (RCC); TSC-associated renal angiomyolipoma; TSC-associated subependymal giant cell astrocytoma (SEGA); and partial-onset seizures related to TSC.

    • briviact

      (brivaracetam)
      UCB, Inc.
      Usage: BRIVIACT is indicated for the treatment of partial-onset seizures in patients aged 1 month and older.

    • gabapentin

      (gabapentin)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Gabapentin capsules are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.

    • lacosamide

      (lacosamide)
      Sintetica US LLC
      Usage: Lacosamide Injection is indicated for treating partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.

    • levetiracetam

      (Levetiracetam)
      Tris Pharma Inc
      Usage: Levetiracetam is indicated for treating partial-onset seizures in patients aged 1 month and older. It is also approved as adjunctive therapy for myoclonic seizures in patients aged 12 and older with juvenile myoclonic epilepsy, and for primary generalized tonic-clonic seizures in patients aged 6 and older with idiopathic generalized epilepsy.

    • oxcarbazepine

      (Oxcarbazepine)
      Ajanta Pharma USA Inc.
      Usage: Oxcarbazepine extended-release tablets are indicated for the treatment of partial-onset seizures in patients aged 6 years and older.

    • oxtellar xr

      (OXCARBAZEPINE)
      Supernus Pharmaceuticals, Inc.
      Usage: Oxtellar XR is indicated for the treatment of partial-onset seizures in patients aged 6 years and older.

    • pregabalin

      (PREGABALIN)
      Eskayef Pharmaceuticals Limited
      Usage: Pregabalin Capsules are indicated for managing neuropathic pain related to diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, fibromyalgia, and as adjunctive therapy for partial-onset seizures in patients aged 1 month and older.

    • qudexy

      (Topiramate)
      Upsher-Smith Laboratories, LLC
      Usage: QUDEXY XR is indicated for the treatment of partial-onset and primary generalized tonic-clonic seizures as initial monotherapy or adjunctive therapy in patients aged 2 and older. It is also approved for the preventive treatment of migraines in patients aged 12 and older.

    • topiramate

      (topiramate spinkle)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Topiramate is indicated for monotherapy in treating partial-onset or primary generalized tonic-clonic seizures in patients aged 2 and older. It is also used as adjunctive therapy for various types of seizures, including those associated with Lennox-Gastaut syndrome, and for the preventive treatment of migraine in patients aged 12 and older.